These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8960447)

  • 1. The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol.
    Basu S; Senior R; Raftery EB; Lahiri A
    Eur Heart J; 1996 Dec; 17 Suppl F():43-7. PubMed ID: 8960447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial.
    Basu S; Senior R; Raval U; van der Does R; Bruckner T; Lahiri A
    Circulation; 1997 Jul; 96(1):183-91. PubMed ID: 9236433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group.
    Weiss R; Ferry D; Pickering E; Smith LK; Dennish G; Krug-Gourley S; Lukas MA
    Am J Cardiol; 1998 Oct; 82(8):927-31. PubMed ID: 9794346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
    van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
    Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
    Dargie HJ
    Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol in ischaemic heart disease.
    Prichard BN
    Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
    van der Does R; Eberhardt R; Derr I; Ehmer B; Rudorf J; Uberbacher HJ
    Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilating beta-blockers in heart failure.
    Raftery EB
    Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Dubova TV
    Klin Med (Mosk); 2001; 79(12):13-6. PubMed ID: 11840802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients.
    Basu S; Senior R; Dore C; Lahiri A
    BMJ; 1996 Oct; 313(7061):844-8. PubMed ID: 8870569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome associated with carvedilol therapy.
    Kowalski BJ; Cody RJ
    Am J Cardiol; 1997 Sep; 80(5):669-70. PubMed ID: 9295009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).
    Fonarow GC; Lukas MA; Robertson M; Colucci WS; Dargie HJ
    Am Heart J; 2007 Oct; 154(4):637-44. PubMed ID: 17892984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective potential of carvedilol.
    Ruffolo RR; Bril A; Feuerstein GZ
    Cardiology; 1993; 82 Suppl 3():24-8. PubMed ID: 8106160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Dunn CJ; Lea AP; Wagstaff AJ
    Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
    Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy.
    Bøttcher M; Refsgaard J; Gøtzsche O; Andreasen F; Nielsen TT
    Am J Cardiol; 2002 Jun; 89(12):1388-93. PubMed ID: 12062733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.